206 related articles for article (PubMed ID: 25880552)
1. Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay.
Grossini E; Bellofatto K; Farruggio S; Sigaudo L; Marotta P; Raina G; De Giuli V; Mary D; Pollesello P; Minisini R; Pirisi M; Vacca G
PLoS One; 2015; 10(4):e0124742. PubMed ID: 25880552
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan modulates programmed forms of cell death through K(ATP) channels and nitric oxide.
Uberti F; Caimmi PP; Molinari C; Mary D; Vacca G; Grossini E
J Cardiovasc Pharmacol; 2011 Feb; 57(2):246-58. PubMed ID: 21107279
[TBL] [Abstract][Full Text] [Related]
3. Protective effects elicited by levosimendan against liver ischemia/reperfusion injury in anesthetized rats.
Grossini E; Pollesello P; Bellofatto K; Sigaudo L; Farruggio S; Origlia V; Mombello C; Mary DA; Valente G; Vacca G
Liver Transpl; 2014 Mar; 20(3):361-75. PubMed ID: 24273004
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel.
Grossini E; Molinari C; Caimmi PP; Uberti F; Vacca G
Br J Pharmacol; 2009 Jan; 156(2):250-61. PubMed ID: 19154424
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan inhibits interleukin-1β-induced apoptosis through activation of Akt and inhibition of inducible nitric oxide synthase in rat cardiac fibroblasts.
Okada M; Yamawaki H
Eur J Pharmacol; 2015 Dec; 769():86-92. PubMed ID: 26528797
[TBL] [Abstract][Full Text] [Related]
6. Human Chorionic Gonadotropin Protects Vascular Endothelial Cells from Oxidative Stress by Apoptosis Inhibition, Cell Survival Signalling Activation and Mitochondrial Function Protection.
Surico D; Farruggio S; Marotta P; Raina G; Mary D; Surico N; Vacca G; Grossini E
Cell Physiol Biochem; 2015; 36(6):2108-20. PubMed ID: 26279419
[TBL] [Abstract][Full Text] [Related]
7. Improved myocardial function with supplement of levosimendan to Celsior solution.
Zhou HY; Zhang LN; Zheng MZ; Wang LL; Chen YY; Shen YL
J Cardiovasc Pharmacol; 2014 Sep; 64(3):256-65. PubMed ID: 24785343
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.
Grossini E; Molinari C; Pollesello P; Bellomo G; Valente G; Mary D; Vacca G; Caimmi P
J Pharmacol Exp Ther; 2012 Aug; 342(2):376-88. PubMed ID: 22566668
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan protects human hepatocytes from ischemia-reperfusion injury.
Brunner SN; Bogert NV; Schnitzbauer AA; Juengel E; Moritz A; Werner I; Kornberger A; Beiras-Fernandez A
PLoS One; 2017; 12(11):e0187839. PubMed ID: 29145424
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms contributing to the protective effect of levosimendan in liver ischemia-reperfusion injury.
Ibrahim MA; Abdel-Gaber SA; Amin EF; Ibrahim SA; Mohammed RK; Abdelrahman AM
Eur J Pharmacol; 2014 Oct; 741():64-73. PubMed ID: 25094034
[TBL] [Abstract][Full Text] [Related]
11. The Ca²⁺-calmodulin-Ca²⁺/calmodulin-dependent protein kinase II signaling pathway is involved in oxidative stress-induced mitochondrial permeability transition and apoptosis in isolated rat hepatocytes.
Toledo FD; Pérez LM; Basiglio CL; Ochoa JE; Sanchez Pozzi EJ; Roma MG
Arch Toxicol; 2014 Sep; 88(9):1695-709. PubMed ID: 24614978
[TBL] [Abstract][Full Text] [Related]
12. Anti-Vascular Endothelial Growth Factors Protect Retinal Pigment Epithelium Cells Against Oxidation by Modulating Nitric Oxide Release and Autophagy.
De Cillà S; Farruggio S; Vujosevic S; Raina G; Filippini D; Gatti V; Clemente N; Mary D; Vezzola D; Casini G; Rossetti L; Grossini E
Cell Physiol Biochem; 2017; 42(5):1725-1738. PubMed ID: 28743128
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effect of levosimendan against homocysteine-induced mitochondrial stress and apoptotic cell death in H9C2.
Aminzadeh A; Mehrzadi S
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):395-399. PubMed ID: 30446219
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan is a mitochondrial K(ATP) channel opener.
Kopustinskiene DM; Pollesello P; Saris NE
Eur J Pharmacol; 2001 Oct; 428(3):311-4. PubMed ID: 11689188
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological Pre- and Postconditioning With Levosimendan Protect H9c2 Cardiomyoblasts From Anoxia/Reoxygenation-induced Cell Death via PI3K/Akt Signaling.
Schauer A; Barthel P; Adams V; Linke A; Poitz DM; Weinbrenner C
J Cardiovasc Pharmacol; 2021 Mar; 77(3):378-385. PubMed ID: 33662980
[TBL] [Abstract][Full Text] [Related]
16. Modulation of programmed forms of cell death by intracoronary levosimendan during regional myocardial ischemia in anesthetized pigs.
Grossini E; Caimmi PP; Platini F; Molinari C; Uberti F; Cattaneo M; Valente G; Mary DA; Vacca G; Tessitore L
Cardiovasc Drugs Ther; 2010 Feb; 24(1):5-15. PubMed ID: 20162343
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological preconditioning by levosimendan is mediated by inducible nitric oxide synthase and mitochondrial KATP channel activation in the in vivo anesthetized rabbit heart model.
Das B; Sarkar C
Vascul Pharmacol; 2007 Oct; 47(4):248-56. PubMed ID: 17728191
[TBL] [Abstract][Full Text] [Related]
18. The cardioprotective effects of levosimendan: preclinical and clinical evidence.
Pollesello P; Papp Z
J Cardiovasc Pharmacol; 2007 Sep; 50(3):257-63. PubMed ID: 17878752
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan pretreatment improves survival of septic rats after partial hepatectomy and suppresses iNOS induction in cytokine-stimulated hepatocytes.
Sakaguchi T; Hashimoto Y; Matsushima H; Hishikawa H; Nishizawa M; Okumura T; Kaibori M
Sci Rep; 2019 Sep; 9(1):13398. PubMed ID: 31527618
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?
Onody P; Stangl R; Fulop A; Rosero O; Garbaisz D; Turoczi Z; Lotz G; Rakonczay Z; Balla Z; Hegedus V; Harsanyi L; Szijarto A
PLoS One; 2013; 8(9):e73758. PubMed ID: 24040056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
